Skip to content
OpenCapital
Get started

Achieve Life Sciences ACHV Market capitalization

Market capitalization at other companies

Pfizer logo
PfizerPFE
$159.73B+11.1%
Sionna Therapeutics, Inc. Common Stock logo
Sionna Therapeutics, Inc. Common StockSION
$1.8B—
Philip Morris International logo
Philip Morris InternationalPM
$257.69B+4.3%

Other financials

Income statement

See full
Net income-$10.2M+20.7%
EPS (diluted)-$0.19+48.6%

Balance sheet

See full
Cash & equivalents$28.1M+116%
Total debt$5.6M+332%
Total equity$10.7M+3.9%
Total assets$33.1M+21.0%

Cash flow

See full
Operating cash flow-$6.9M+37.5%
CapEx$750.0—
Free cash flow-$12.4M—

Valuation

See full
Enterprise value$562.71M+439%

Returns & leverage

See full
Return on equity-496.1%-906pp
Debt / equity0.5×+0.4×
Current ratio2.6×-0.9×

Where this comes from

Computed from the period-end share price: $156.53M.

The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Achieve Life Sciences's market capitalization?
Achieve Life Sciences (ACHV) reported market capitalization of $156.53M in Q1 2026.
How has Achieve Life Sciences's market capitalization changed year-over-year?
Achieve Life Sciences's market capitalization increased by 69.0% year-over-year, from $92.61M to $156.53M.
What is the long-term trend for Achieve Life Sciences's market capitalization?
Over 5 years (2020 to 2025), Achieve Life Sciences's market capitalization has grown at a 28.1% compound annual growth rate (CAGR), from $76.57M to $264.57M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.